Market Access Views & Analysis

Views & Analysis

Rises in non-submissions to NICE: do they matter?

Leela Barham asks why companies may choose to not submit their drugs to NICE and keep them off routine commissioning – a trend that appears to be on the rise.

Views & Analysis

A sea-change for pharma? Pandemic commercial models and laun...

Sarah Rickwood looks at how COVID-19 is changing pharma’s commercial models and launch strategies.

R&D

A history of the pharmaceutical industry

Robin Walsh takes a look back at the origins of the industry in the 19th century and its ongoing evolution

Views & Analysis

Covid-19 Wearing mask in an airport departure lounge

Coronavirus pharma news roundup – 14/08/20

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories.

Views & Analysis

Novo Nordisk: Prevention, digital tools and collaboration to...

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he

Views & Analysis

Coronavirus pharma news roundup - 07/08/20

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales.

Rises in non-submissions to NICE: do they matter?

A sea-change for pharma? Pandemic commercial models and laun...

A history of the pharmaceutical industry

Coronavirus pharma news roundup – 14/08/20

Novo Nordisk: Prevention, digital tools and collaboration to...

Coronavirus pharma news roundup - 07/08/20

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks